Drogueria Saimed S.a. DE C.v., Pharmaceutical Import Profile — El Salvador (DGFT 2022–2026)

Name: Drogueria Saimed S.a. DE C.v., Pharmaceutical Import Records from India — 5 Products, $3.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Drogueria Saimed S.a. DE C.v., — Pharmaceutical Importer Profile (2026) | 5 Products, $3.8M Trade | TransData Nexus

Who Are the Verified Indian Suppliers to Drogueria Saimed S.a. DE C.v.,?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Caplin Point Laboratories Limited	$4.4M	227	100.0%

Drogueria Saimed S.a. DE C.v., sources from 1 verified Indian supplier across 137 distinct formulations. The sourcing is highly concentrated — Caplin Point Laboratories Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does Drogueria Saimed S.a. DE C.v., Import?

Formulation	Value	Ships
Ibuprofen soft gelatin capsules 800MG	$250.0K	5
Clarithromycin tablets USP 500MG	$235.0K	6
Sildenafil citrate tablets 100MG	$200.0K	4
Gentamycinbetamethasone and clotrimazole cream 30GM gentamicina + betametasona+ clotrimazol crema 30GM	$150.0K	3
Carbamazepine tablets BP 200MG	$149.3K	7
Omeprazole delayed release capsules usp20mg	$145.4K	7
Ibuwin forte ibuprofen soft gelatin	$100.0K	2
Gentamycinbetamethasone and	$100.0K	2
Gentamycin,betamethasone and clotrimazole cream 30GM gentamicina + betametasona+ clotrimazol crema 30GM	$100.0K	2

Drogueria Saimed S.a. DE C.v., imports 137 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

What Products Does Drogueria Saimed S.a. DE C.v., Import?

Top Products by Import Value

1Vitamin$1.2M 2Clarithromycin$850.0K 3Clotrimazole$729.0K 4Gentamicin$650.0K 5Omega$293.4K

Drogueria Saimed S.a. DE C.v., Therapeutic Categories — 3 Specializations

Drogueria Saimed S.a. DE C.v., imports across 3 therapeutic categories, with Nutritional Supplements (40.8%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Import Portfolio — Top 5 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Vitamin	Nutritional Supplements	$1.2M	55	0.9%	14
2	Clarithromycin	Antibiotics	$850.0K	17	0.9%

Key Metrics

Total Import Value$3.8M

Products5

Shipments117

Categories3

CountryEl Salvador

#1 Rankings0

Indian Suppliers1

Formulations137

Top Categories

Nutritional Supplements40.8%

Antibiotics39.9%

Last updated: March 28, 2026

Drogueria Saimed S.a. DE C.v., — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Drogueria Saimed S.A. de C.V. is a pharmaceutical importer and distributor based in San Salvador, El Salvador. The company specializes in sourcing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily from India. With a total import value of $3.8 million USD and 117 shipments from 2022 to 2026, Drogueria Saimed plays a significant role in the El Salvadorian pharmaceutical market. The company's product portfolio encompasses five key products across three therapeutic categories: Nutritional Supplements, Antibiotics, and Antifungals. Notably, their top five imported products include Vitamin supplements, Clarithromycin, Clotrimazole, Gentamicin, and Omega supplements. All these products are sourced exclusively from Caplin Point Laboratories Limited, an Indian pharmaceutical manufacturer.

2Distribution Network

Drogueria Saimed's distribution network is centered in San Salvador, the capital city of El Salvador. While specific details about their warehouse locations and logistics capabilities are not publicly disclosed, the company's significant import volume suggests a well-established infrastructure capable of handling substantial pharmaceutical shipments. Their geographic coverage likely extends throughout El Salvador, ensuring nationwide distribution of their imported pharmaceutical products.

Supplier Relationship Intelligence — Drogueria Saimed S.a. DE C.v.,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Drogueria Saimed's sourcing strategy exhibits a high degree of concentration, with all 117 shipments from 2022 to 2026 originating from Caplin Point Laboratories Limited. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or geopolitical issues affecting India. However, the consistent volume of imports and the exclusive partnership suggest a stable and reliable relationship between Drogueria Saimed and Caplin Point Laboratories. The absence of alternative suppliers may limit flexibility in response to market changes or supply chain challenges.

2Supply Chain Resilience

The resilience of Drogueria Saimed's supply chain is closely tied to its exclusive relationship with Caplin Point Laboratories Limited. While this partnership ensures consistency in product quality and availability, it also means that any disruptions at Caplin Point Laboratories—such as production issues, regulatory challenges, or logistical problems—could directly impact Drogueria Saimed's ability to meet local demand. The company's reliance on a single supplier may limit its capacity to diversify sourcing options in response to unforeseen events.

3Strategic Implications

Drogueria Saimed's sourcing pattern positions it as a key distributor of Indian pharmaceutical products in El Salvador, particularly in the therapeutic areas of Nutritional Supplements, Antibiotics, and Antifungals. For Indian exporters, establishing a partnership with Drogueria Saimed could provide a direct channel to the Salvadoran market, leveraging the company's established distribution network and market knowledge. However, potential suppliers should be aware of the risks associated with the company's single-source dependency and consider strategies to mitigate supply chain vulnerabilities.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into El Salvador — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for El Salvador

1Regulatory Authority & Framework

In El Salvador, the Ministry of Health (Ministerio de Salud) is the primary regulatory authority overseeing pharmaceutical imports and distribution. The regulatory framework governing pharmaceutical imports includes compliance with Good Manufacturing Practices (GMP), product registration, and adherence to labeling and packaging standards. Indian pharmaceutical products must undergo a registration process with the Ministry of Health to obtain marketing authorization before they can be imported and distributed within El Salvador.

2Import Licensing & GMP

Import licensing in El Salvador requires pharmaceutical companies to obtain authorization from the Ministry of Health, demonstrating compliance with national regulations and standards. GMP certificates from recognized authorities, such as the World Health Organization (WHO) or the European Medicines Agency (EMA), are typically accepted, provided they are current and cover the specific products intended for import. Additionally, wholesale distribution authorization is necessary to legally distribute pharmaceutical products within the country.

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing to ensure they meet El Salvador's quality standards. Stability studies are required to confirm the product's shelf life under local storage conditions. Labeling must be in Spanish and include essential information such as product name, active ingredients, dosage form, manufacturer details, batch number, expiration date, and storage instructions. Serialization may be mandated to enhance traceability and prevent counterfeit products from entering the market.

4Recent Regulatory Changes

Between 2024 and 2026, El Salvador implemented several regulatory changes affecting pharmaceutical imports. These included stricter enforcement of GMP compliance, updated labeling requirements to include additional safety information, and enhanced scrutiny of import licenses to ensure they align with international standards. These changes aim to improve the safety and efficacy of pharmaceutical products available in the Salvadoran market.

TransData Nexus Research · El Salvador regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: Drogueria Saimed S.a. DE C.v., identified across shipments using consignee name normalization, aggregating 3 name variants.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as Drogueria Saimed S.a. DE C.v.,'s capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 117 individual customs records matching Drogueria Saimed S.a. DE C.v.,.
5.Supplier Verification: Drogueria Saimed S.a. DE C.v., sources from 1 verified Indian suppliers across 137 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

5 Products Tracked

3 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Drogueria Saimed S.a. DE C.v.,

Drogueria Saimed S.a. DE C.v., — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Drogueria Saimed S.a. DE C.v.,?

What Formulations Does Drogueria Saimed S.a. DE C.v., Import?

What Products Does Drogueria Saimed S.a. DE C.v., Import?

Top Products by Import Value

Drogueria Saimed S.a. DE C.v., Therapeutic Categories — 3 Specializations

Import Portfolio — Top 5 by Import Value

Key Metrics

Top Categories

Drogueria Saimed S.a. DE C.v., — Corporate Profile & Information

1Company Overview

2Distribution Network

Indian Suppliers

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — Drogueria Saimed S.a. DE C.v.,

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into El Salvador — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

Drogueria Saimed S.a. DE C.v., — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to Drogueria Saimed S.a. DE C.v.,

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — Drogueria Saimed S.a. DE C.v.,

What products does Drogueria Saimed S.a. DE C.v., import from India?

Who supplies pharmaceuticals to Drogueria Saimed S.a. DE C.v., from India?

What is Drogueria Saimed S.a. DE C.v.,'s total pharmaceutical import value?

What therapeutic categories does Drogueria Saimed S.a. DE C.v., focus on?

Get Full Drogueria Saimed S.a. DE C.v., Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology